ALLO holder plans sale of 22,900 shares

ALLO had a Form 144 filed to permit the sale of 22,900 shares of its common stock through Morgan Stanley Smith Barney LLC on or about 02/02/2026, to be sold on NASDAQ with an aggregate market value of $40,214.69.

Rhea-AI Filing Summary

ALLO had a Form 144 filed to permit the sale of 22,900 shares of its common stock through Morgan Stanley Smith Barney LLC on or about 02/02/2026, to be sold on NASDAQ with an aggregate market value of $40,214.69.

The shares were acquired on 01/31/2026 as restricted stock vesting under a registered compensation plan, with compensation listed as the form of payment. The filing notes that 224,730,144 shares of common stock were outstanding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ALLO disclose?

The filing discloses a planned sale of 22,900 ALLO common shares on NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of $40,214.69. It is a notice of intent to sell restricted stock that recently vested under a registered compensation plan.

How many ALLO shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 22,900 shares of ALLO common stock. These shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, reflecting an aggregate market value of $40,214.69 at the time indicated in the filing.

When were the ALLO shares being sold under Form 144 acquired?

The 22,900 ALLO shares were acquired on January 31, 2026, as restricted stock vesting under a registered plan. The filing identifies the issuer as the source of the shares and lists compensation as the nature of payment for this vesting transaction.

What is the approximate sale date and market for the ALLO Form 144 shares?

The filing lists an approximate sale date of February 2, 2026, for the 22,900 ALLO shares. The shares are to be sold on the NASDAQ exchange, using Morgan Stanley Smith Barney LLC as the broker for executing the transactions.

How many ALLO shares were outstanding according to this Form 144?

The document states that 224,730,144 shares of ALLO common stock were outstanding. This figure provides context for the relative size of the planned 22,900-share sale described in the Form 144 notice filed for the account of the selling holder.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 05:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001362155
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALLOGENE THERAPEUTICS, INC.
SEC File Number	001-38693
Address of Issuer	210 East Grand Avenue South San Francisco CALIFORNIA 94080
Phone	(650) 457-2700
Name of Person for Whose Account the Securities are To Be Sold	EARL DOUGLAS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	22900	40214.69	224730144	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2026	Restricted stock vesting under a registered plan	Issuer			22900	01/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Earl Douglas
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)